| NCT05351502 | A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors | RECRUITING | PHASE1 | 2022-08-14 | 2025-06-30 | 2025-05-30 |
| NCT04685720 | A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients | COMPLETED | NA | 2020-12-07 | 2022-10-10 | 2022-07-28 |
| NCT04606407 | Inhaled NO for the Treatment of Viral Pneumonia in Adults | COMPLETED | NA | 2020-11-25 | 2022-08-07 | 2022-08-07 |
| NCT04456088 | Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial) | WITHDRAWN | PHASE2 | 2020-07-15 | 2020-12-15 | 2020-11-15 |
| NCT04397692 | Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) | TERMINATED | NA | 2020-06-13 | 2020-09-30 | 2020-09-30 |
| NCT04060979 | Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis | COMPLETED | PHASE2 | 2019-11-06 | 2020-04-02 | 2020-03-02 |
| NCT03208764 | Inhaled Nitric Oxide for Patients With MABSC | COMPLETED | PHASE2 | 2017-07-24 | 2019-04-11 | 2018-05-01 |
| NCT03053388 | Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis | COMPLETED | PHASE3 | 2017-03-05 | 2018-04-28 | 2018-04-28 |
| NCT01958944 | Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis | COMPLETED | PHASE1, PHASE2 | 2013-12 | 2015-11 | 2015-11 |
| NCT01768884 | Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With Bronchiolitis | COMPLETED | PHASE1, PHASE2 | 2013-01 | 2016-01 | 2016-01 |